Filing
4th Quarter - Report
Reporting period
4th Quarter 2025
Oct 1 - Dec 31 · Posted Jan 20, 2026
Expenses
$75,000.00
What this organization spent lobbying with its own staff.
Reported using B: the three
LDA methods count different costs, so an expenses figure is
not comparable across filers that used different ones.
Client based in
District of Columbia
Lobbyists on this filing
3
-
ANNA HYDEPreviously held: Vice President, Advocacy and Access
-
ALISA VIDULICH CASAVANT New on this filingPreviously held: Policy Director
-
HAYLEY DEMPSEY New on this filingPreviously held: Federal Affairs Manager
Government bodies contacted
10
Lobbying activity
3
Medicaid
S.46 - Health Care Affordability Act of 2025 Safe Step Act H.R.5509 S.864 - HELP Copays Act PBM Reform Act of 2025 PAAT Act "Patient Access to Autoimmune Treatments Act" Ensuring Patient Access to Critical Breakthrough Products Act CDC Arthritis Program - Appropriations Congressionally Directed Medical Research Program - Appropriations ATPCs Arthritis Research Medicaid
CDC Arthritis Program - Appropriations Congressionally Directed Medical Research Program - Appropriations H.R.1, the One Big Beautiful Bill